Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry.

Elena WolodimeroffPankaj GargAndrew J SwiftGraham FentNigel LewisDominic RogersAthanasios CharalampopoulosAbdallah Al-Mohammad

Published in: Open heart (2022)

When all variables associated with mortality are considered, none of the cardiovascular agents are associated with the improved survival of patients with suspected HF, raised NT-proBNP but no HF on echocardiography.

Keyphrases

heart failure
acute heart failure
left ventricular
computed tomography
healthcare
cardiovascular events
risk factors
emergency department
free survival
type diabetes
adverse drug